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Abstract 
Bone marrow (BM)-derived dendritic cells (DC) are the most potent known antigen (Ag) presenting cell in vivo 
and in vitro. Detailed analysis of their properties and mechanisms of action requires an ability to produce large 
numbers of DC. Although DC have been isolated from several rat tissues, including BM, the yield is uniformly low. 
We describe a simple method for the propagation of large numbers of DC from rat BM and document cell yield with 
the rat DC marker, OX-62. 
After depletion of plastic-adherent and Fc+ cells by panning on dishes coated with normal serum, residual BM 
cells were cultured in gelatin coated flasks using murine rGM-CSF supplemented medium. Prior to analysis, 
non-adherent cells were re-depleted of contaminating Fc+ cells. Propagation of DC was monitored by double 
staining for FACS analysis (major histocompatibility complex (MHC) class n+ /OX-62+, OX-19-). Functional assay. 
morphological analysis and evaluation of homing patterns of cultured cells revealed typical DC characteristics. MHC 
class II and OX-62 antigen expression increased with time in culture and correlated with allostimulatory ability. DC 
yield increased until day 7, when 3.3 X 106 DC were obtained from an initial 3 X 108 unfractionated BM cells. 
Significant numbers of DC can be generated from rat BM using these simple methods. This should permit analysis 
and manipulation of rat DC functions in vivo and in vitro. 
Keywords: Dendritic cell; Bone marrow; GM-CSF; OX-62; (Rat) 
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1. Introduction 
Bone marrow (BM)-derived dendritic cells 
(DC) arc the most potent stimulator cells of pri-
0022-1759/95/$09.50 © 1995 Elsevier Science B.V. All rights reserved 
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mary mixed leukocyte reactions (MLR) and also 
serve as powerful antigen-presenting cells in the 
priming of CD4 + T cells in vivo (Steinman, 1991; 
Steinman and Cohn, 1973). Furthermore, based 
on the recent appreciation of donor hematolym-
phoid cell chimerism persisting up to 30 years 
after kidney or liver transplantation (Starzl et aI., 
1992, 1993b), donor-derived cells with DC char-
acteristics have been implicated in the induction 
of tolerance after solid organ transplantation 
(Demetris et aI., 1993; Starzl et aI., 1992, 1993b). 
Although a hypothesis by which DC might medi-
ate the induction of allograft tolerance has been 
proposed (Demetris et aI., 1994; Starzl et aI., 
1993a) (based on the permissive effect of im-
munosuppressants on leukocyte migration be-
tween graft and host), a definite mechanism has 
not yet been established. 
The investigation of mechanisms by which DC 
function, both in vivo and in vitro, requires effec-
tive culture of these cells, with production of 
large numbers for analysis. With the availability 
of recombinant (r) murine GM-CSF, several re-
ports have shown that it is possible to grow large 
numbers of DC from murine Onaba et aI., 1992a; 
Scheicher et aI., 1992) and human (Reid et aI., 
1992) bone marrow (BM) and this cytokine has 
been used to promote the survival of lymph-borne 
DC for up to 72 h in the rat (MacPherson, 1989; 
MacPherson et aI., 1989). Cytokines have not 
been used to enhance DC yield from fresh rat 
bone marrow cultures, even though the species is 
used extensively to investigate many immunologi-
cal phenomena. 
In this report, we describe a simple and highly 
reproducible technique for the propagation of rat 
BM-derived DC. Phenotypic analysis of these cells 
was enhanced by the use of OX-62, the new 
murine monoclonal antibody directed against an 
integrin-like rat DC surface marker (Brenan and 
Puklavec, 1992). This method utilises several of 
the previously described properties of rat DC 
precursors to maximise the yield of these cells in 
culture, nam61y their lack of adherence to plastic 
flasks (Klinkert et aI., 1980, 1982), FcR status 
(Klinkert et aI., 1980, 1982) and their partial 
dependence on murine rGM-CSF (MacPherson, 
1989; MacPherson et aI., 1989). In addition to 
these measures, tissue culture flasks were coated 
with gelatin to augment DC growth (in a fashion 
analogous to the use of type 1 collagen to pro-
mote the maturation of liver-derived DC (Lu et 
aI., 1994». Using this approach, bulk cultures of 
DC can readily be generated from rat BM, as 
documented by their morphology, functional abil-
ity in mixed lymphocyte reactions (MLR) and 
their expression of MHC class II (Banuls et aI., 
1993; Bowers and Berkowit:<3, 1986; Hart and 
Fabre, 1981) and the DC-specific surface marker, 
OX62 (Brenan and Puklavec, 1992). 
2. Materials and methods 
2.1. Collection of rat bone marrow 
7-9-week-old Lewis rats (LEW; RT11), pur-
chased from Harlan Sprague Dawley (Indianapo-
lis, IN) and maintained in conventional animal 
facilities, were used as BM cell donors. After 
killing, using methoxyflurane inhalational anes-
thesia (Pitman-Moore, Mundelein, IL), BM cells 
were removed from the femurs and tibias and 
washed twice with complete medium (RPMI 1640 
medium containing 5% FBS, 5 J,Lg/ml of gentam-
icin, 2 mM L-glutamine and 10 mM Hepes buffer). 
The medium and all supplements were purchased 
from Gibco (Life Technologies, Grand Island, 
NY). 
2.2. Coating of tissue culture flasks with gelatin 
A 1 % solution of gelatin (cell culture tested, 
300 bloom porcine skin gelatin; purchased from 
Sigma Cell Culture Reagents, St. Louis, MO) in 
PBS was used to coat tissue culture flasks at 
room temperature for 2 h (2 mljflask, allowed to 
air-dry). Flasks were washed twice with PBS be-
fore use for BM culture. 
2.3. Depletion of Fe + and plastic-adherent (FcPA) 
BM cells 
To optimise the variety of Fc receptor binding 
sites with which to deplete FcPA cells, petri dishes 
(100 xIS mm, Falcon #1029; Becton-Dickinson, 
------------ ---
M. Chen-Woan et al. / Journal of Immunological Methods 178 (J995) 157-171 159 
Palo Alto, CA) were coated overnight at 4°C with 
a mixture of 10% normal goat serum and 5% 
normal human AB serum in PBS. After washing 
twice with PBS to remove any excess serum, 
50 X 106 BM cells, suspended in 6 ml complete 
medium, were added to each petri dish and incu-
bated at room temperature for 1 h with gentle 
swirling at 30 min. The non-adherent FcPA de-
pleted cells were gently removed and the dishes 
were subjected to two further gentle washes to 
remove any remaining non-adherent cells. The 
pooled non-adherent cells were then used for 
culture. Vsing the same protocol, non-adherent 
cells removed from cultures were re-depleted of 
FcPA cells before functional assay and pheno-
typic analysis, as indicated below. 
2.4. Propagation of DC from rat bone marrow 
Approximately 120 X 106 FcPA depleted BM 
cells were cultured at a concentration of 3 X 
106/ml in each 75 cm2 Falcon tissue culture 
flask, with or without gelatin coating. Complete 
medium, further supplemented with 10% FBS, 
5 X 10- 5 M 2-ME, 0.5 J,Lg/ml of NMA (N-y-
monomethyl-L-argine, Schweizerhall, Piscataway, 
NJ) and an optimal concentration of mouse rGM-
CSF (0.4 ng/ml; R&D System, Minneapolis, 
MN), was used as a culture medium. Cultures 
were fed every 2nd day by exchanging half the 
medium for fresh rGM-CSF containing medium, 
without discarding any cells (medium being ex-
changed was centrifuged and any cells were re-
stored to the culture flask). In some experiments, 
rGM-CSF was further supplemented with recom-
binant human TNF-a (50 V /ml; Genzyme, Cam-
bridge, MA). 
2.5. Mixed leukocyte reactions (MLR) 
Lymph node cells from syngeneic LEW (RTll) 
and allogeneic ACI (RTla ) and PVG (RTle ) rats 
(Harlan Sprague Dawley) were used as respon-
ders. DC-rich cultured BM cells and fresh unfrac-
tionated LEW spleen cells (positive controls) were 
used as stimulators. One way MLR were per-
formed in V-shaped 96-well microtest plates 
(Falcon #3077). A constant number of respon-
ders (9 X 104/well) was used against various 
numbers of y-irradiated (20 Gy) stimulator cells 
in each assay. Stimulator to responder ratios 
ranged from 3:1 to 1:729 and with this system the 
peak response occurred between days 3 and 4. 
Each MLR was labelled with 1 J,LCijml final 
concentration of [3H]thymidine (2 CijmM; New 
England Nuclear, Beverly, MA) for 7 h prior to 
harvesting with an automatic harvester (Skatron, 
Lier, Norway). Thymidine incorporation was de-
termined using a liquid scintillation counter (1205 
Betaplate, Wallac, Gaithersburg, MD). Results 
are expressed as mean counts per minute (cpm) 
± 1 standard deviation. 
2.6. Immunofluorescence labelling and FACS anal-
ysis 
DC yield from BM cultures was monitored by 
double staining with the mAbs OX-6 and OX-62 
using flow cytometric analysis. Throughout these 
experiments, cultured DC were confirmed to be 
OX-19- to avoid the possibility of any cross-reac-
tion between OX-62 and a 'Y /8 T cell population. 
OX-6 (MHC class 11), OX-19 (pan-T cell), ED-1 
(monocyte /macrophage) and ED-2 (a monocyte 
subset) mAbs were purchased from Accurate 
Chemical and Scientific Corp., Hicksville, NY. 
OX-62 (rat DC) was a generous gift donated by 
M.J. Puklavec (Serotec, Oxford, UK). Double im-
munofluorescence staining was performed as pre-
viously described (Chen-Woan and Goldschnei-
der, 1991) and 104 gated events were analysed for 
each sample on an Epics Elite flow cytometer 
(Coulter, Hialeah, FL). 
2. 7. In vivo homing studies and immunocytochem-
istry 
FcPA depleted BM was cultured for 6 days 
with rGM-CSF. Non-adherent cells were re-
moved, re-depleted of FcP A cells, washed in 
RPMI 1640 and injected into the penile vein of 
anesthetised BN rats, treated with 1 mg/kg per 
day of FK506. 1-3 days later the spleen was 
removed, frozen in OCT (Miles, Elkhart, IN) and 
stored at - 70°C. LEW cells were localised in the 
recipient BN tissue using Cy3-conjugated L-21-6 
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Table 1 
The proliferation of cells in unfractionated rat BM cultures (as measured by level of DNA synthesis) can be increased by 
supplementation with recombinant murine GM-CSF and also by the utilisation of gelatin-coated culture flasks in the presence of 
GM-CSF 
Time Cytokine No gelatin a 
Day 0 c No cytokine 53.8 
rGM-CSF d 52.9 
rGM-CSF + TNFa e 53.5 
Day 3 No cytokine 6.5 
rGM-CSF 9.2 • 
rGM-CSF + TNFa 9.7 
Day 5 No cytokine 2.1 
rGM-CSF 6.8 •• 
rGM-CSF + TNFa 6.1 
Gelatin a 
51.2 
54.4 
53.4 
6.3 
11.8 *' 
12.6 
2.9 
9.8 " 
8.1 
Amount of increase b 
x 1.0 
X 1.3 (p = 0.07) 
X 1.0 
X 1.4 
X 1.4 (p = 0.05) 
X 1.3 
Further supplementation with human TNF-a does not improve the level of proliferation achieved. 
a Data in cpm X 10 -3. Cultures were pulsed with [ 3H]thymidine for 7 h. 
b Ratio of gelatin/no gelatin. 
e'Day 0' = fresh unfractionated rat BM. 
d Recombinant murine GM-CSF at a concentration of 0.4 ng/m!. 
C Recombinant human TNF-a at 50 U /m\. 
• p = 0.06 vs. no cylokine; * p < 0.0005 vs. no cytokine. 
(a mAb which reacts with the invariant chain of 
class II MHC of LEW and other rat strains, but 
not BN (Murase et al., 1991)) with a standard 
direct immunofluorescent technique. Normal 
LEW and BN spleen sections were used as posi-
tive and negative controls, respectively. 
2.8. Ultrastructural studies 
Transmission electron microscopy (TEM) was 
performed on pellets of centrifuged cells after 
standard dehydration, embedding, sectioning and 
staining, using a lEOL 100-CX microscope (lEOL 
Technics, Tokyo, 1 apan). For scanning electron 
microscopy (SEM), cells were placed on cover-
slips coated in poIY-L-lysine (Sigma), critical point 
dried, sputter coated with gold and viewed using 
a JEOL lSM-T300 microscope. 
All results are expressed as mean ± 1 standard 
deviation. Student's t test was used where appro-
priate and p < 0.05 was accepted as statistically 
significant. 
3. Results 
3.1. Effect of GM-CSF and gelatin-coated flasks 
The use of gelatin-coated tissue culture flasks 
increased the proliferation of cells in unfraction-
ated BM cultures to 1.3-1.4 times that seen with-
out gelatin (p = 0.05 at day 5) (Table 1). Further 
improvement could be achieved by the addition 
of murine rGM-CSF which significantly (p < 0.01) 
increased cell proliferation thrcc and five days 
after commencing cultures of unfractionated rat 
Fig. 1. Depletion of Fc+ and adherent cells before culture of unfractionated rat BM (E, D, F, H) augments the stimulatory ability 
of nonadherent cells obtained from day 5 cultures supplemented with GM-CSF in gelatin-coated flasks (D), and increases the 
percentage of DC from 5.2% (C, unfractionated BM) to 8.5% of gated cells. Depletion of Fc+ and adherent cells from the NA 
cells obtained after culture can enrich the DC population up to 17.5% (H), with an associated increase in allostimulatory ability, 
while reducing ED-1 + contamination to 2.5%. Examination of the adherent cells remaining in the panning plates (E and F) 
revealed that 40% of these cells are ED-1 + while less than 7'1c are OX-62+ Throughout this experiment, nonadherent cells from 
cultures of Fc f and adherent cell depleted BM showed consistently more OX-62+ cells and higher levels of stimulatory ability in 
MLR than were achieved with unfractionated BM (A, C, E, G). Results shown are representative data from three experiments. 
MLR ~ mixed lymphocyte reaction; FACS ~ flow cytometry. 
FACS (% positive) 
Not 
available 
ED-I 11.6 
ED-2 4.3 
OX-62 5.2 
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Unfractionated BM culture 
MLR 
Adherent 
A. 
, 
,_0 
10
31
1 
~ :~:::~~-K-
...--//- ----,,-
102 
1.2 3.7 11.1 
Nonadherent 
c. 
33.3 
12 3.7 11.1 33.3 
Fc+ and adherent cell depleted BM culture 
FACS (% positive) 
Adherent 
" 
-.-LEW I 
-.-ACI 
-6-PVG 
B. '.' MED 
.------------------ ---. 
.-.---,.---
1.2 3.7 11.1 33.3 
Nonadherent 
D. 
IKKKK~::: 
._0/ 
0' 
/ .. --K~-- ......... -
1.2 3.7 11.1 33.3 
Not 
availabJe 
ED-I 10.9 
ED-2 3.2 
OX-62 8.5 
Panning after culture yielded: c.p.m. 
ED-I 40.6 
ED-2 9.0 
OX-62 3.8 
ED-I 10.9 
ED-2 50 
OX-62 6.8 
10' 
Adherent (Fc+) 
E. 
"---,----. ~---~ 
1.2 3.7 11.1 33.3 
Nonadherent (Fc-) 
G. 
102j 
~-------------12 3.7 11.1 33.3 
Adherent (Fc+) 
F. 
/e __ 
/ 0 
.. // .. //------.----
/ 
1.2 3.7 11.1 33.3 
Nonadherent (Fc-) 
1.2 3.7 11.1 33.3 
---- Number of stimulator cells (x 102) 
ED-I 40 j 
ED-2 18.3 
OX-62 6.9 
ED-I 2.5 
ED-2 0.9 
OX-62 17.5 
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Fig. 2. A: phase contrast microscopy ( x 400) of a day 6 culture of Fc+ and plastic-adherent (FcPA) cell depleted BM. Cells with 
dendritic morphology can be visualised throughout the field and some lightly adherent, small clusters of growing cells (arrows) are 
also present. High power views ( x 1000) are shown of a single growing cluster Cleft inset) and of non-adherent cells with 
characteristic dendritic morphology which have been aspirated from a day 5 culture and viewed on a microscopy slide. B: Giemsa 
staining ( x 1000) of cytospin FcPA cells from day 7 culture. 
BM (Table 1). Furthermore, we observed that 
using gelatin-coated flasks increased the number 
of small clusters of dendritic shaped cells floating 
throughout the culture medium, in comparison to 
cultures without gelatin, and that more adherent 
cells were present in gelatin-negative cultures. In 
three experiments the mean yield of non-adher-
ent cells from day 6 cultures was 13.5 ± 2% and 
8.2 ± 0.7% of the initial number used (for cul-
tures with and without gelatin, respectively: p < 
0.02). Since gelatin coated flasks improved the 
yield of non-adherent cells, all subsequent cul-
tures used this technique. Further supplementa-
tion with human TNF-a, as may be required in 
cultures of human bone marrow (Reid et aI., 
1992), did not augment cell proliferation (Table 
1). 
3.2. Effect of retammg non-adherent cells when 
re-feeding cultures 
As removal of non-adherent cells during cul-
ture improves the yield of DC from mouse pe-
-> 
Fig. S. Immunohistochemical staining of allogeneic spleen 3 days after intravenous injection of 10 x 106 cultured DC, depleted in 
Fc+ and plastic-adherent cells. LEW cells were localised in the recipient BN tissue using Cy3-conjugated L-21-6 (which reacts with 
the invariant chain of class II MHC of LEW, but not BN) using a standard direct immunofluorescent technique. A positive (red) 
stained LEW DC is seen in the area of the T-dependent periarteriolar lymphatic sheath. 
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ripheral blood Onaba et al., 1992b) and BM (In-
aba et al., 1992a), we compared two different 
techniques of growing DC from rat BM. In one 
method we discarded the non-adherent cells ev-
ery 2 days when adding fresh medium to the 
cultures, as previously described in murine DC 
systems Onaba et al., 1992a, b). For the second 
method, we retained the non-adherent cells by 
resuspending any floating cells (in the medium 
being exchanged) in fresh culture medium and 
returning them to the culture flask. The allostim-
ulatory ability of non-adherent cells obtained from 
GM-CSF-supplemented day 8 cultures of unfrac-
tionated rat BM was significantly improved by 
retaining the floating cells that would have been 
removed during medium exchanges using the 
'murine' technique, at stimulator to responder 
ratios of 1:27 the MLR against PVG were 21747 
± 1484 and 6800 ± 1024, respectively (p < 0.01). 
These results are entirely consistent with previous 
reports that mature rat DC do not adhere to 
culture flasks (Klinkert et aI., 1980, 1982). Thus 
the removal of non-adherent cells during culture 
discards many of the matuHyDC and lowers the 
MLR activity obtained. Non-adherent cells were 
therefore retained for all subsequent experi-
ments. 
3.3. Effect of depletion of FcPA cells from BM 
prior to culture 
After depletion of FcPA cells by panning on 
serum-coated petri dishes, between 54 and 65% 
of the amount panned were recovered as non-ad-
herent cells (60.5 ± 4.3% (mean ± 1 SD); n = 7). 
When uncoated plates were used, the percentage 
of non-plastic-adherent cells was approximately 
80%. 
The upper panels in Fig. 1 (experiments per-
formed three times, representative data shown) 
demonstrate that the stimulatory ability of cul-
tured cells could be markedly increased by de-
pleting FcPA cells before initiating BM cultures 
(B vs. A; D vs. C). Non-adherent cells from 
unfractionated cultures (C) showed 3.5 times 
greater stimulatory ability than unfractionated 
LEW splenocytes, while non-adherent cells from 
cultures of FcPA depleted cells (D) were found 
to be 31 times stronger than fresh spleen cells. 
Staining with the DC specific mAb, OX-62 re-
vealed that the yield of OX-62 + cells could be 
increased from 5.2% to 8.5% by depleting BM of 
FcPA cells before culture (C vs. D). These results 
confirm that DC precursors are retained in a 
non-adherent and Fc- fraction of normal rat 
bone marrow. Although the initial number of 
cells in FcPA depleted BM cultures was only 60% 
of that in unfractionated cultures, the yield of 
non-adherent cells after 5 days of culture was 
similar (28.2 X 106 vs. 36 X 106), i.e., a particular 
cell yield could be obtained more efficiently after 
depletion of FcPA cells. 
3.4. Effect of depletion of FcPA cells at the end of 
the culture period 
To further enrich the purity of DC at the end 
of the culture period, non-adherent cells from 
day 5 cultures of unfractionated BM, and FcP A 
depleted BM were panned using serum-coated 
petri dishes, as before (Fig. 1, lower panels). The 
phenotypic profiles and allostimulatory ability of 
the two populations were then compared. BM 
depleted of FcPA cells before culture yielded 
consistently better results (F and H vs. E and G). 
The results also showed that panning with serum 
coated petri dishes could efficiently remove con-
taminating monocytes from cultured BM cells. 
Adherent fractions after panning (E and F) con-
sisted largely of ED-1 + and ED-2+ labelled 
Fig. 3. Flow cytometric analysis of Fc+ and plastic-adherent (FcPA) cell-depleted BM cultured with GM-CSF in gelatin-coated 
flasks. Cultures were commenced on days -9, -7, -5, -3 and -1. Non-adherent cells were re-depleted of FcPA cells before 
analysis. Column A shows the forward and side scatter profiles of cultured cells and gives the percentage of total cells which falls 
within the gate where DC are found. Many of the cells outside this gate are granulocytes. Column C shows results after 
double-staining with the rat DC-specific mAb OX-62 and OX-6 (MHC class II) (isotype controls in column B). 'Day 0' cells were 
obtained from fresh BM depleted of FcPA cells on the day of analysis. The maximum percentage of double OX-62 + /OX-6 + cells 
was seen in day 7 cultures (32.1%). 
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monocytes, whereas very few of these cells re-
mained in the non-adherent cell fractions (G and 
H). OX-62+ cells accounted for 6.9% and 17.5% 
of the adherent and non-adherent fractions, 
repectively (F and H). 
A correlation between the percentage of OX-
62 + cells and the stimulatory ability of day 5 BM 
cultures was also clearly demonstrated through-
out this experiment (Fig. 1, A-H). During the 
course of the experiment the stimulatory power 
of non-adherent and adherent fractions was 132 
(H) and 32 (F) times greater than that of fresh 
spleen controls, respectively. Light microscopic 
examination of non-adherent fractions showed 
many of these cells to havc dendritic morphology 
(Figs. 2A and 2B). 
3.5. Kinetics of growth j maturation of rat EM 
cultures 
To ascertain the time of optimum DC yield, a 
detailed growth curve was performed. Since rat 
DC express both MHC class II and an a chain-like 
integrin recognised by OX-62 as surface markers, 
it was possible to study the kinetics of their 
development in BM culture by sequentially docu-
menting the presence of double labelled cells. On 
days -9, -7, -5, -3 and -1,240 x 10 6 FcPA 
depleted fresh BM cells were set up in culture 
using a standardised technique. All cells were 
harvested on day 0 and, with the exception of 
'day 0' cells (FcPA depleted fresh BM), cultures 
were re-panned with normal serum coated plates 
to deplete monocytes before functional assess-
ment and phenotypic analysis (Figs. 3 and 4). 
Assaying all cultures on the same day with identi-
cal batches of panning solutions, media, etc., min-
imised variations that might occur between differ-
ent time points. 
Fig. 3 demonstrates that the emergence of 
OX6+ jOX62 + jOX19- DC using this culture 
technique is a function of the time spent in cul-
ture up to day 9. Although the yield of 
OX6+ jOX62+ jOX19- DC increased up to day 
7, on day 9 it diminished (day 1 = 0.2 X 106 ; day 
3 = 2.0 X 10°; day 5 = 2.3 X 106 ; day 7 = 3.3 X 
106 ; day 9 = 0.3 X 106 ). The stimulatory ability of 
these cultures at different time points also 
strongly correlated with the intensity of expres-
sion of class II and OX-62 (Fig. 4). Day 9 cultures 
were the most potent stimulators on a cell-far-cell 
basis. A simple count of OX-62 + cells does not 
accurately reflect DC potency or maturity (com-
pare day 7 and day 9, Figs. 3 and 4). These 
findings demonstrate that the maturation of DC 
is a dynamic event during which cells upregulate 
surface marker expression in conjunction with 
their increasing allostimulatory ability. 
The yield of DC is summarised in Table 2. 
After depletion of FcP A cells from 300 X 106 
unfractionated BM cells, 0.6 X 106 DC are seen. 
When these cells are cultured for up to 7 days 
and redepleted of FcPA cells, a maximum of 
3.3 X 106 OX6+ jOX62 + cells can be obtained. 
The allostimulatory ability of these cells increases 
up to day 9, at which stage they are between 597 
(PVG responder) and 665 (ACI responder) times 
more potent allostimulators than equivalent num-
bers of unfractionated LEW splenocytes. 
3.6. In vivo homing patterns of DC 
To confirm the homing properties of cultured 
DC, non-adherent cells from day 6 cultures of 
FcPA depleted BM were redepleted of contami-
nating monocytes using serum coated plates. Al-
logeneic recipient animals were then injected in-
travenously with 10 X 106 cultured cells. Exami-
nation of the recipient's spleen 2-3 days after 
injection revealed homing of the cells to the 
periarteriolar lymphatic sheath, as expected for 
DC (Fig. 5). 
3. 7. Ultrastructure of DC 
For TEM, day 6 BM cultures, depleted of 
monocytes by repanning, were further subjected 
to BSA gradient fractionation as previously de-
scribed (Klinkert et aI., 1980, 1982). The low 
density fraction (p = 1.048) consisted of greater 
than 90% DC, and representative cells are shown 
in Fig. 6. The allostimulatory capability of this 
low density fraction was approximately 1600 times 
that of fresh spleen cells (data not shown). As 
previously described, TEM demonstrated many 
cells with long dendritic processes, lobed nuclei 
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Fig. 4. Allostimulatory data for the cells analysed by flow cytometric analysis in Fig. 3. After y-irradiation, various numbers of cells 
were used to stimulate a constant number of responder lymphocytes (9 x 104/well) from syngeneic (LEW) and third party (ACI 
and PVG) cervical lymph nodes; MED contained medium in place of responder cells. Cultures were maintained for 3 days and 
labelled with [3Hlthymidine 7 h before harvesting. A continuous increase in the allostimulatory ability of cultured cells was seen up 
to day 9, at which stage the cells were between 597 (PVG responder) and 665 (ACI responder) times more potent than fresh LEW 
splenocytes (between 2.7 x 105 and 1 x 104 LEW splenocytcs/well were used as positive controls). 
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Table 2 
The enhancement of cell yield using this protocol for the propagation of rat 8M-derived DC (kinetics experiment data for day 1 
and clay 9, mean of three experiments for day 3, day 5 and day 7) 
Day NA ce lls recove red Mean yield of NA cells OX-6 + jOX-62 + cells 
from cultures (x 10 6 ) after panning (x 106 ) after panning (x 106 ) 
o ' 300 " 180 06 
69 29 0.2 
3 72 44 2.0 
5 38 14 2.3 
7 27 14 3.3 
9 7.2 25 0.3 
Ratio of allostimulatory ability of DC 
to thai of fresh spleen in MLR 
ACI responder PVG responder 
68 34 
124 105 
178 145 
177 183 
665 597 
Afte r panning of unfractionaled 8M, 180 X 10 6 Fc " and plastic-adhe rent depleted cells were obtained (0.6 X 106 D C). Ce lls were 
cultured and ana lysed 1-9 days later. OX-6 + jOX-62 + cells increased from 0.2 X 10° to a maximum of 3.3 x 106 by day 7. The 
allostimuJatory abi lity of these cells increased until day 9, at which stage they were approximately 600 times more potent 
alloslimulators than fresh LE W sp lenocytes in MLR. 
a Fresh unfractionated bone marrow cells from LEW rat. 
Fig. 6. Transmission e lectron micrograph (x 6300) of nonadherent cel ls removed from day 6 cultures of BM with GM-CSF in 
gelatin-coated flasks. The cells were re-depleted of F c+ and plastic-adherent cells and further purified on a BSA gradient before 
analysis. These cells exhibit numerous, long dendritic processes, have irregularly shaped nuclei with promioent nucleoli and have 
profuse mitochondria. 
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and profuse mitochondria (Steinman and Cohn, 
1973). 
4. Discussion 
Although short-term culture (1-3 days) to aid 
in the isolation of DC from various rat tissues, 
including lymph nodes, skin, thoracic duct lymph 
and peritoneal exudate cells, has been described 
previously (Bowers and Berkowitz, 1986; Klinkert 
et aI., 1980, 1982; MacPherson, 1989; MacPher-
son et aI., 1989), only two reports describe the 
culture of DC from rat bone marrow. In these 
papers, Bowers and Berkowitz (1986) used 
serum-free medium while Klinkert (1984) used 
medium supplemented with ConA-stimulated 
spleen cell supernatant to promote DC growth. 
With thc advances in molecular biology in the 
past decade, it is now possible to obtain recombi-
nant cytokines for definitive studies of 
hemopoiesis, both in vivo and in vitro. 
In murine systems, large numbers of BM de-
rived DC have been generated using species-
specific rGM-CSF alone Onaba et aI., 1992a). In 
contrast, propagation of DC from CD34 + stem 
cells from human BM and cord blood requires a 
combination of tumor necrosis factor (TNF) and 
GM-CSF (Caux et aI., 1992; Reid et aI., 1992). 
Recombinant murine GM-CSF has been used in 
the rat to improve recovery at 72 h of thoracic 
duct lymph-borne DC (MacPherson, 1989; 
MacPherson et aI., 1989), however the cytokine 
has not been used to enhance DC yield from 
fresh rat bone marrow cultures. In this paper we 
demonstrate that murine rGM-CSF significantly 
promotes the proliferation of cells from rat BM 
(as measured by level of DNA synthesis). The 
addition of a low concentration of human rTNF-a 
(50 U ImO does not improve proliferation, al-
though this may be related to the inactivity of this 
cytokine in the rat (rat TNF-a is not currently 
available). 
GM-CSF promotes the growth of monocytes, 
maerophages and granulocytes in cultures of BM, 
probably by stimulation of a common myeloid 
precursor cell. Apart from reducing DC purity, 
monocytes can also express class II Ag as a sur-
face marker. Hence, simple determination of the 
number of class II + cells in culture, as has been 
performed in previous reports (Klinkert et aI., 
1982; MacPherson, 1989), may not adequately 
differentiate between monocytes and DC. The 
recent availability of a specific mAb for the rat 
DC (OX-62) (Brenan and Puklavec, 1992) makes 
it possible to reliably monitor the development of 
BM-derived DC in culture. Although OX-62 does 
not stain all DC (Brenan and Puklavec, 1992), it 
does allow us to standardise culture techniques 
for the propagation of DC from the rat, an ani-
mal used widely for investigating allograft-recipi-
ent interactions. Therefore in this paper, putative 
DC (confirmed to be OX-19- and therefore not 
y 18 T cells) are double labelled with OX-62 and 
the MHC class II marker, OX-6, allowing an 
accurate (although conservative) determination of 
cell phenotype and number. Using double la-
belling of cultured cells, we demonstrate that the 
yield of DC is a function of the time spent in 
culture. Furthermore, their stimulatory activity in 
MLR strongly correlates with the intensity of 
expression of these surface antigens. This is not 
surprising, because OX-62 identifies the a sub-
unit of an integrin-like molecule (Brenan and 
Puklavec, 1992), up regulation of which would be 
expected under the influence of GM-CSF. Simi-
larly, the increased expression of class II on ma-
ture DC is not unexpected, as DC are well known 
to be the most potent of Ag presenting cells 
(Steinman, 1991; Steinman and Cohn, 1973). 
The question remains whether these DC are 
growing, or simply maturing from precursors pre-
sent in the initial BM culture. Taken in conjunc-
tion, three separate pieces of evidence suggest 
that DC are actually being propagated in this 
culture system and are not only maturing. First, 
the number of DC gradually increases up to day 7 
in culture (Table 2) in conjunction with a signifi-
cant increase in the DNA synthesis of cells from 
BM in the presence of GM-CSF. Second, using 
light microscopy and TEM to examine day 7 
cultures, we observed DC with different lengths 
of distinct cytoplasmic veils, probably reflecting 
different stages of activation and maturation, as 
previously reported for human DC (Patterson et 
aI., 1991). Finally, discontinuous BSA gradient 
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centrifugation showed that, even as late as day 7, 
many cells with the appearance of what may be 
immature DC (fuzzy border, short dendrites, small 
veils (Caux et aI., 1992; Patterson et aI., 1991)), 
were present in the high density fraction, possibly 
due to their immature status. 
Gelatin (a water soluble, denatured form of 
collagen) has previously been used to support 
endothelial cell cultures in our laboratory (Colson 
et aI., 1990). Because the propagation of murine 
DC on type 1 collagen-coated tissue culture plates 
has been found to promote the maturation of 
'immature' liver-derived DC in the presence of 
rGM-CSF (Lu et aI., 1994), we assessed the effect 
of gelatin on rat DC growth. Both the yield and 
the potency of DC were enhanced by culture in 
gelatin-coated flasks, although the mechanism by 
which gelatin might promote the growth and/or 
maturation of these cells is unknown (Lu et aI., 
1994). This effect may be mediated directly by 
gelatin, or indirectly through its binding to fi-
bronectin in culture media. Gelatin has been 
used for many years for the purification of plasma 
and tissue fibronectins that in turn have been 
shown to play an important role in cell differenti-
ation (D'Ardenne and McGee, 1984; Hynes and 
Yamada, 1982). Macrophages and neutrophils are 
producers of fibronectin (Beaulieu et aI., 1987; 
Tsukamoto et aI., 1981) and consequently, in cul-
tures supplemented with GM-CSF, there is a 
continuous supply of fibronectin in the medium. 
Further study is required to determine how gelatin 
improves the yield of BM-derived DC. 
Unfortunately the rat DC precursor is a float-
ing cell. This eliminates the option of decanting 
off granulocytes and other contaminating cells at 
an early stage (as performed in mouse DC cul-
tures). Previous studies have shown, however, that 
DC precursors in rat BM are Fc- and do not 
adhere to plastic dishes and that these cells can 
be enriched by removing the plastic-adherent cells 
and depleting Fc+ cells by using sheep red blood 
cell rosetting (Klinkert et aI., 1982; Klinkert et aI., 
1980). To accomodate both properties of the DC 
precursors, we panned BM cell suspensions on 
normal serum-coated petri dishes prior to culture 
of rat BM in rGM-CSF supplemented medium 
and repanned the non-adherent cultured cells 
prior to analysis. This extremely simple technique 
allows the generation of a population of cells 
which are 32% double-positive for OX-6 and 
OX-62. Furthermore, these cells have more than 
100 times more stimulatory capacity than fresh 
spleen cell controls in MLR. Simple depletion of 
the adherent BM cells prior to culture can in-
crease the stimulatory ability of the cells obtained 
by 30-fold. Furthermore, culture of these cells in 
gelatin-coated flasks significantly increases the 
yield of DC obtained. This procedure can readily 
be adopted in any cell culture laboratory. 
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